AI is rapidly advancing, with significant strides being made toward achieving more powerful and capable systems.

Isomorphic Labs aims to start clinical trials for AI-designed drugs by year-end, potentially revolutionizing drug discovery timelines. Market optimism persists under Trump 2.0, with a focus on big ...

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive officer.Most Read ...

We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where Alphabet Inc. (NASDAQ:GOOGL) stands against the other AI stocks. AI is ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups race to turn algorithmic magic into actual treatments. The potential of ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year, Bloomberg News reported, citing the company's CEO Demis Hassabis. Isomorphic is ...

Alphabet (GOOGL) is expected to release its fourth-quarter earnings results after the closing bell on Tuesday.

We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where Alphabet Inc. (NASDAQ:GOOGL) stands against the other AI stocks. AI is rapidly ...

AI is rapidly advancing, with significant strides being made toward achieving more powerful and capable systems. While challenges and limitations have arisen along the way, the field is still ...

The integration of AI in healthcare as a means by which to enhance diagnostic accuracy and treatment planning also appeared ...